(Q39602426)

13 September 2017

Positive regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by mammalian target of rapamycin (mTOR) in RINm5F cells (English)

1 reference

13 September 2017

1 reference

Marc-Olivier Frégeau

1

1 reference

PubMed ID

21268094

13 September 2017

Yannik Régimbald-Dumas

series ordinal

2

1 reference

PubMed ID

21268094

13 September 2017

Gaétan Guillemette

series ordinal

3

1 reference

13 September 2017

1 February 2011

1 reference

Journal of Cellular Biochemistry

13 September 2017

1 reference

13 September 2017

112

1 reference

13 September 2017

2

1 reference

13 September 2017

723-733

1 reference

New insights into mTOR signaling: mTORC2 and beyond

13 September 2017

1 reference

Protein kinase C phosphorylates the inositol 1,4,5-trisphosphate receptor type 2 and decreases the mobilization of Ca2+in pancreatoma AR4-2J cells

21 January 2018

1 reference

The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus

21 January 2018

1 reference

mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer

21 January 2018

1 reference

Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex

21 January 2018

1 reference

The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C

21 January 2018

1 reference

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

21 January 2018

1 reference

Inositol trisphosphate receptor Ca2+ release channels.

21 January 2018

1 reference

Upstream and downstream of mTOR

21 January 2018

1 reference

Astrocytes in adult rat brain express type 2 inositol 1,4,5-trisphosphate receptors.

21 January 2018

1 reference

Progesterone potentiates calcium release through IP3 receptors by an Akt-mediated mechanism in hippocampal neurons.

21 January 2018

1 reference

Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling

21 January 2018

1 reference

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

21 January 2018

1 reference

Role of inositol trisphosphate receptors in autophagy in DT40 cells

21 January 2018

1 reference

Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors

21 January 2018

1 reference

Regulation of TORC1 by Rag GTPases in nutrient response

21 January 2018

1 reference

Insulin potentiates Ca2+ signaling and phosphatidylinositol 4,5-bisphosphate hydrolysis induced by Gq protein-coupled receptor agonists through an mTOR-dependent pathway

21 January 2018

1 reference

Progesterone potentiates IP(3)-mediated calcium signaling through Akt/PKB.

21 January 2018

1 reference

The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes

21 January 2018

1 reference

In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin

21 January 2018

1 reference

Critical role for hypothalamic mTOR activity in energy balance

21 January 2018

1 reference

The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential.

21 January 2018

1 reference

Insulin promotes the association of heat shock protein 90 with the inositol 1,4,5-trisphosphate receptor to dampen its Ca2+ release activity

21 January 2018

1 reference

Bidirectional transport of amino acids regulates mTOR and autophagy

21 January 2018

1 reference

cAMP-dependent protein kinase enhances inositol 1,4,5-trisphosphate-induced Ca2+ release in AR4-2J cells

21 January 2018

1 reference

Mammalian target of rapamycin (mTOR) phosphorylates inositol 1,4,5-trisphosphate receptor type 2 and increases its Ca(2+) release activity

21 January 2018

1 reference

A link between protein translation and body weight

21 January 2018

1 reference

Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site

21 January 2018

1 reference

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

21 January 2018

1 reference

The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1

21 January 2018

1 reference

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

21 January 2018

1 reference

LKB1 and AMP-activated protein kinase control of mTOR signalling and growth

21 January 2018

1 reference

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

The contribution of serine residues 1588 and 1755 to phosphorylation of the type I inositol 1,4,5-trisphosphate receptor by PKA and PKG.

21 January 2018

1 reference

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

21 January 2018

1 reference

Association of type 1 inositol 1,4,5-trisphosphate receptor with AKAP9 (Yotiao) and protein kinase A

21 January 2018

1 reference

Functional consequences of phosphomimetic mutations at key cAMP-dependent protein kinase phosphorylation sites in the type 1 inositol 1,4,5-trisphosphate receptor

21 January 2018

1 reference

Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR.

21 January 2018

1 reference

Type I, II and III inositol 1,4,5-trisphosphate receptor co-immunoprecipitation as evidence for the existence of heterotetrameric receptor complexes

21 January 2018

1 reference

Structure and Function of Inositol 1,4,5-Trisphosphate Receptor

21 January 2018

1 reference

21 January 2018

A tale of two messengers

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.23006

1 reference

13 September 2017

1 reference

PubMed ID

21268094